These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 901638)

  • 1. HLA-A3 linked C3 deficiency in multiple sclerosis.
    Caputo D; Bisaccia G; Sabbadini MG; Zibetti A
    Boll Ist Sieroter Milan; 1977 Jul; 56(3):260-3. PubMed ID: 901638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple sclerosis with reduced and with normal levels of complement in the blood. Clinical and genetic correlation.
    Trouillas P; Moindrot J; Betuel H; Quincy C; Aimard G; Devic M
    Rev Neurol (Paris); 1976 Oct; 132(10):684-704. PubMed ID: 1006010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypocomplementaemic multiple sclerosis: heterozygous C2 deficiency linked to HLA A10, B18.
    Trouillas P; Berthoux F; Betuel H; Boisson D; Aimard G; Devic M
    Lancet; 1976 Nov; 2(7993):1023. PubMed ID: 62239
    [No Abstract]   [Full Text] [Related]  

  • 4. Association of histocompatibility haplotype HLA-A3-B7 with multiple sclerosis.
    Bertrams HJ; Kuwert EK
    J Immunol; 1976 Nov; 117(5 Pt.2):1906-12. PubMed ID: 993587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypocomplementaemic and normocomplementaemic multiple sclerosis. Genetic determinism and association with specific HLA determinants (B18 and B7).
    Trouillas P; Betuel H
    J Neurol Sci; 1977 Jul; 32(3):425-35. PubMed ID: 886365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA antigens in multiple sclerosis in Alsace.
    Rumbach L; Tongio MM; Warter JM; Marescaux C; Grange D; Mayer S; Collard M
    Biomed Pharmacother; 1985; 39(7):385-9. PubMed ID: 3830266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA typing on Italian multiple sclerosis population.
    Zibetti A; Cazzullo CL; Smeraldi E; Scorza-Smeraldi R
    Boll Ist Sieroter Milan; 1978 Jan; 56(6):539-43. PubMed ID: 147093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA antigen segregation analysis in multiple sclerosis (MS) families.
    Bertrams J; Kuwert E
    Z Immunitatsforsch Immunobiol; 1976 Nov; 152(3):200-8. PubMed ID: 1007375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Complement markers Bf and C4 in multiple sclerosis].
    Fauchet R; Madigand M; Gueguen-Duchesne MY; Papin J; Sabouraud O; Genetet B
    Rev Neurol (Paris); 1984; 140(6-7):422-5. PubMed ID: 6611572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Histocompatibility antigens in multiple sclerosis patients].
    Khondkarian OA; Tananov AT; Zavalishin IA; Nevskaia OM; Kut'ina RM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(2):7-10. PubMed ID: 7234266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histocompatibility (HLA) antigens and multiple sclerosis in Israelis.
    Brautbar C; Amar A; Cohen I; Kahana E; Cohen T; Bloch D; Grosse-Wilde H; Alter M
    Isr J Med Sci; 1982 May; 18(5):631-4. PubMed ID: 7096048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Complement 3 level in the cerebrospinal fluid in multiple sclerosis].
    Wajgt A
    Neurol Neurochir Pol; 1980; 14(3):275-82. PubMed ID: 7412984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Disseminated sclerosis. Possible correlation between clinical forms and HLA groups (author's transl)].
    Madigand M; Fauchet R; Oger J; Sabouraud O
    Nouv Presse Med; 1981 Jun; 10(28):2349-52. PubMed ID: 7267340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes of serum complement and of circulating immune complexes in patients with multiple sclerosis.
    Cojocaru M; Serbănescu A; Cojocaru IM
    Rom J Intern Med; 1993; 31(2):131-7. PubMed ID: 8268831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple sclerosis immunogenetics. A possible correlation with human leukocyte HL-A antigens.
    Cazzullo CL; Smeraldi E
    Arzneimittelforschung; 1975 Nov; 25(11):1826-8. PubMed ID: 1106444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple sclerosis: HLA studies in Italy.
    Conighi C
    Ital J Neurol Sci; 1987 Jun; Suppl 6():41-3. PubMed ID: 3498705
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunogenetical aspects of multiple sclerosis with special regard to the HLA-histocompatibility system.
    Bertrams J
    Boll Ist Sieroter Milan; 1978 Jan; 56(6):506-15. PubMed ID: 147092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multiple sclerosis and the histocompatibility system].
    Khondkarian OA; Tananov AT; Zavalishin IA; Nevskaia OM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(2):167-71. PubMed ID: 6176089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The third component of complement (C'3) level in patients with uveitis.
    Koliopoulos J; Theodossiadis G; Palimeris G
    Mod Probl Ophthalmol; 1976; 16():239-43. PubMed ID: 1250229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which complement assays and typings are necessary for the diagnosis of complement deficiency in patients with lupus erythematosus? A study of 25 patients.
    Boeckler P; Meyer A; Uring-Lambert B; Goetz J; Cribier B; Hauptmann G; Lipsker D
    Clin Immunol; 2006 Nov; 121(2):198-202. PubMed ID: 16987709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.